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Involvement of somatostatin in breathing control
before and after birth, and in perinatal
and infant sudden unexplained death
Anna Maria Lavezzi, Giulia Ottaviani, Luigi Matturri
Institute of Pathology, University of Milan, Italy
The distribution of the somatostatin was studied by immunohistochemistry on serial sections of the
56 brain stems from subjects aged from 30 gestational weeks to 12 postnatal months, dying of both known
and unknown causes. The unexplained deaths included 13 sudden intrauterine deaths, 4 sudden neona-
tal deaths and 24 sudden infant deaths. We observed intense somatostatin positivity in the cell bodies and
fibres of many brainstem nuclei prevalently involved in the respiratory activity (parabrachial/Kölliker-Fuse
complex, locus coeruleus, hypoglossus nucleus, dorsal vagus motor nucleus, tractus solitarii nucleus, am-
biguus nucleus, and reticular formation) in stillbirths. Only in 8 foetuses with unexplained death the hypo-
glossus nucleus was somatostatin-negative. In the postnatal deaths, the immunopositivity was prevalently
limited to the ventrolateral and ventral subnuclei of the tractus solitarii nucleus. In 13 sudden infant death
victims and in one case of death due to pneumonia, somatostatin-positivity was also present in the hypo-
glossus nucleus. We concluded that: 1) the somatostatin is an important foetal breathing-inhibitor, but it
becomes important for the physiological control of respiration immediately after delivery; 2) functional
alterations of the hypoglossal nucleus can occur in both sudden perinatal and infant deaths and contri-
bute to the induction of both fatal breathing movements in foetuses and abnormal ventilatory control in
infants leading to irreversible apneic phenomena.
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INTRODUCTION
Somatostatin (SS) is a neuropeptide with a wide dis-
tribution in the central nervous system (CNS), which con-
trols various physiological processes, including cardiovas-
cular, digestive and respiratory activity [9, 12, 28, 37],
through interaction with specific receptors [31, 32, 35].
Experimental studies have shown that SS is parti-
cularly expressed in the nuclei of the brainstem in-
volved in ventilatory regulation, such as the tractus
solitarius nucleus, dorsal vagus motor nucleus, am-
biguus nucleus, parabrachialis nuclei [4, 7, 30, 39].
Several authors have demonstrated that local in-
jections of SS into the brainstem of rats and cats in-
duce changes in respiratory rhythm and can also
cause ventilatory depression and irreversible apnea
[5, 13, 14, 18].
In man, it was observed that intravenous admin-
istration of SS could induce inhibition of the venti-
latory response to hypoxia [11, 27]. However, only
few controversial studies have described the distri-
bution of SS and of its receptors in the human brain
[2, 3, 6, 8, 33].
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To obtain basic information about the expression
of SS in the human CNS and, in particular, to evaluate
the possible involvement of this neurotransmitter in
unexplained perinatal and in sudden infant death syn-
drome, which we have frequently ascribed to morpho-
logical alterations of respiratory centres [1, 22–25],
we performed an immunohistochemical study on serial
sections of the brainstems of subjects aged from
30 gestational weeks to 12 postnatal months, who
died of known and unknown causes.
MATERIAL AND METHODS
We examined 56 brainstems obtained at autopsy
from 18 stillbirths and 38 infants aged from 30 gesta-
tional weeks to 12 postnatal months. Six cases were
neonatal deaths that occurred in the first week of life
(Table 1).
In 13 stillborns, 4 newborns and 24 infants death
occurred suddenly and unexpectedly and remained
unexplained after a thorough case investigation and
a complete autopsy, including examination of the placen-
tal disk, umbilical cord and membranes in foetuses.
A diagnosis of Sudden Intrauterine Unexplained
Death (SIUD) was established for the 13 stillborns. The
4 newborns died of Sudden Neonatal Unexplained
Death (SNUD). The Sudden Infant Death Syndrome
(SIDS) was diagnosed in the 24 infants, who all died
unexpectedly after the first month of life. 70% of the
SIDS cases were 3 to 6 months old.
In the other cases, the cause of death was estab-
lished at autopsy, and included atypical location of the
umbilical cord (2 foetuses), congenital heart diseases
(2 foetuses; 2 newborns; 1 infant), pneumonia (1 foe-
tus; 2 infants), acute infections (5 infants).
All brainstems were fixed in 10% phosphate-buffered
formalin, processed and embedded in paraffin, accor-
ding to the protocol routinely followed by our Institute
[26] and available on the web site: http://users.unimi.it/
~pathol/sids/_e.html. Briefly, transverse serial sections
were made through the entire extension: the block was
cut at intervals of 30 mm. For each level, twelve 5 mm
sections were obtained, three of which were routinely
stained for histological examination using alternately
hematoxylin-eosin, Bielschowsky and Klüver-Barrera
stains, two for the SS immunohistochemical study and
the other 7 were saved and stained as deemed neces-
sary for further investigations. The number of levels and
consequently of serial sections throughout the entire
brainstem varied in relation to the age of the analysed
subjects. In foetuses, from the 30th week of gestation,
the average number of sections was 360 (correspond-
ing to 30 groups of 12 serial sections), while in term
foetuses and/or in newborns it was 600 (30 groups). In
infants of 3–4 months or over 6 months an average of
900 and 1,400 sections were obtained from 75 and
120 levels, respectively.
The principal nuclei in the histological serial sec-
tions were analysed, namely the parabrachial/Kölliker-
-Fuse complex (PB/KF), the locus coeruleus (LC), the
hypoglossus nucleus (HypoglN), the dorsal vagus mo-
tor nucleus (DvmN), the tractus solitarii nucleus (TsN),
the ambiguus nucleus (AmbN), the arcuate nucleus
(ArcN), the ventrolateral respiratory reticular formation
(RF) and the inferior olivary nucleus (OliN). Plates in
the Olszewski and Baxter atlas [29] were used as refe-
rences.
SS immunohistochemistry
Lyophilised rabbit serum diluted in PBS (Novocast-
lab- Newcastle, UK) was used in this study. This antise-
rum recognised the N-terminal part of SS-28, composed
of 28 amino acids.
SS immunoreactivity was visualised by the peroxi-
dase-antiperoxidase (PAP) method. In order to neut-
ralise endogenous peroxidase, sections were pretrea-
ted with a solution of 0.3% hydrogenase peroxide for
20 minutes. After rinsing in buffer, sections were ex-
posed for 48 hours to the specific primary antiserum
diluted 1:150 at 25°C. After 10 min in the buffer, the
site of antigen-antibody reaction was revealed with
antirabbits immunoglobuline followed by PAP complex.
The unlabeled antiserum was placed on the sections
(1:200 dilution) for 2 h at room temperature. The sec-
tions were then exposed to PAP complex for 2 h at
dilution 1:200. The sites of peroxidase activity were
visualised with 0.3% hydrogen peroxide in buffer con-
Table 1. Sources of the brainstems
Victim groups Diagnosis
 Fetuses (n =18) SIUD (n = 13)
Malpositioned umbilical cord (n = 2)
Congenital heart disease (n = 2)
Pneumonia (n = 1)
 Newborns (n = 6) SNUD (n = 4)
Congenital heart disease (n = 2)
  Infants (n = 32) SIDS (n = 24)
Congenital heart disease (n = 1)
Pneumonia (n = 2)
Acute infections (n = 5)
SIUD — Sudden Intrauterine Unexplained Death, SNUD — Sudden Neonatal Unex-
plained Death, SIDS — Sudden Infant Death Syndrome
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taining 0.04% diaminobenzidine tetrahydrochloride
and 0.5 g nickel ammonium sulfate. Slides were
rinsed, dehydrated, mounted and examined by light
microscopy.
Statistical analysis
The association of the SS positivity in the different
brainstem nuclei and victim groups was evaluated by
Cox regression analysis. The statistical value of the
correlation was established at the p < 0.05 level using
one-way analysis of variance followed by t-test or Stu-
dent’s t-test.
RESULTS
Histological examination of serial sections of the
56 brainstems often showed a normal morphology of
all the principal nuclei throughout their extension. Struc-
tural congenital abnormalities of the arcuate nucleus
were observed in 15 of the sudden death victims (5 SIUD,
1 SNUD and 9 SIDS) (37%) and in none of the subjects
that died of other causes (Table 2).
Different degrees of the arcuate nucleus develop-
mental defect were observed: bilateral hypoplasia in
4 cases (n. 1 SIUD and 3 SIDS), monolateral hypoplasia
in 1 case (SIDS), partial hypoplasia in 5 cases (3 SIUD,
and 2 SIDS), neuronal depletion and/or delayed neuronal
maturation in 3 cases (SIDS) and agenesis in 2 cases
(1 SIUD, 1 SNUD).
The hypoplasia of the RF was also present together
with ArcN hypodevelopment in 4 SIUD cases.
The immunohistochemical study showed prevalent
SS expression in the nuclei of the brainstem involved in
respiratory activity but a variable distribution (Table 2).
In particular, in stillbirths, an intense positivity was con-
stantly seen in the cell bodies and fibres of the PB/KF
and LC in the pons and in the TsN, DvN, AmN and RF in
the medulla oblongata. In 10 foetuses (5 SIUD with hypo-
plasia of the ArcN and 5 deaths of an identified cause),
positivity of the neurons of the HypoglN was also ob-
served. In further 8 cases, all classified as SIUD, this
nucleus gave a negative result for SS. In these 8 vic-
tims, the ArcN showed a normal morphology.
In the positive nuclei, the presence of SS was rela-
tively constant along their caudo-rostral axis except in
the DvN, where the more caudal sections gave nega-
tive results.
In the postnatal deaths, an abrupt reduction of
SS-positivity was evident. In fact, even in the first days
of life, we observed a moderate number of positive cell
bodies limited to the ventrolateral and ventral subnu-
clei of the NTS and sometimes to the DvN and LC. In
13 SIDS cases, all with a normal structure of the ArcN,
and in one case of death due to pneumonia, concomi-
tant with the positivity in such nuclei, a large group of
intensely positive motoneurons was also present in the
HypoglN (Fig. 1).
Table 2. Distribution of SS and arcuate nucleus hypoplasia in the cases studied
Victim groups SS positivity Arc N hypoplasia
PB/KF LC TsN DvN AmN RF HypoglN N° cases N° cases
Fetuses SIUD + + + + + + – 8 –
(n = 18) (n = 13) + + + + + + + 5 5




(n = 6) (n = 4) – (+) +* (+) – – – 4 1
Other causes
(n = 2) – – +* (+) – – – 2 –
Infants SIDS – – +* (+) – – – 2 –
(n = 32) (n = 24) – (+) +* (+) – – + 13 –
– (+) +* (+) – – – 9 9
Other – – +* + – – + 1 –
causes – (+) +* (*) – – – 7 –
(n = 8)
SIUD — Sudden Intrauterine Unexplained Death, SNUD — Sudden Neonatal Unexplained Death, SIDS — Sudden Infant Death Syndrome, PB/KF — parabrachial/Kölliker-Fuse
complex; LC — locus coeruleus, TsN — tractus solitarii nucleus, DvmN — dorsal vagus motor nucleus, AmbN — ambiguus nucleus, RF — ventrolateral reticular formation,
HypoglN — hypoglossus nucleus, ArcN — arcuate nucleus.
+* = SS-positivity limited to neurons of the ventral and ventrolateral subnuclei of the TsN.
(+) = SS-positivity only in some cases.
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Figure 1. Somatostatin-immunoreactive neurons of the hypoglossus nucleus in a victim of sudden infant death syndrome (male,
3 months).
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Thus, we found that an altered behaviour of SS in
the HypoglN is significantly related to sudden death
(p < 0.05). In fact, the observation of a SS-negative
HypoglN is more frequent in SIUD than in foetal deaths
of known causes. On the contrary, the frequency of
SS-positivity of the HypoglN is higher in SIDS than in
infants dead of other causes.
DISCUSSION
The results obtained in this study give rise to various
considerations.
During foetal development, SS-containing neurons
are diffusely distributed in many nuclei of the brainstem,
showing a particular concentration in the nuclei involved
in respiratory activity (TsN, DvN, AmN, RF, HypoglN, ArcN,
PB-KF, LC). This positivity is found in both cell bodies
and fibres.
After birth, SS positivity immediately decreases.
Its presence is constantly restricted to the perikarya
of a smaller number of brainstem nuclei (DvN, LC and,
above all, the ventrolateral and lateral subnuclei of
the TsN). This pattern of positivity is stable as early
as from the first days of life and is maintained up to
12 months.
Similarly, in studies of few cases, Carpentier et al.
[2, 3] and Chigr et al. [6] showed that SS-receptors are
expressed in many regions of the human brainstem
during development in the foetus, particularly in the LC,
DvN and TsN, and disappear during infancy and adult-
hood.
Therefore, we can assume that the high presence
of the SS in respiratory centres of the foetal brainstems
is strongly involved in the inhibition of intrauterine
breathing.
Additionally, the persistence of positive cell bodies
in nuclei involved in the regulation of respiration, par-
ticularly, in two subnuclei of the TsN (ventral and vent-
rolateral) after birth, suggests another important role
for SS in the modulation of the ventilatory rhythm.
In fact, the ventrolateral and ventral regions of the
TsN are known to contain dense concentrations of res-
piratory neurons. Electrophysiological studies [10, 17,
18] have shown the existence of two populations of
neurons in these subnuclei of the TsN (R-alpha and
R-beta), which are considered to be excitatory and in-
hibitory respiratory neurons, respectively.
The involvement of SS in the control of ventilatory
activity is also shown by the observation, in cases with
a positive DvN, that immunoreactive neurons are pre-
valently located in the rostral-intermediate extent of this
nucleus. In the caudal sections, SS-immunostaining is
constantly negative.
These data are in agreement with several experimen-
tal studies showing that the DvN contains different neuro-
chemical subpopulations with distinct physiological roles.
It is well established that the caudal region of this nucleus
is involved in vagal reflexes controlling gastric motility. In-
stead, the motor neurons with respiratory-related activity
are located in the rostral-intermediate levels [21, 36].
The SS-positivity observed in this study, in some
cases, relatively to LC, suggests that even this nucleus
may participate in the ventilatory activity. Besides, se-
veral authors have demonstrated in experimental stu-
dies that the noradrenergic neurons of the LC play a crit-
ical role in the regulation of the sleep cycle oscillations
and of the wakefulness [15, 16, 19, 20].
Therefore, our results show a dual function of SS in
the human brainstem: 1) inhibition of foetal breathing
and 2) control of the respiratory rhythm after delivery.
Another interesting result of this study is the diffe-
rent expression of SS in the HypoglN in cases of unex-
plained death compared to cases with an explained
cause of death. In fact, we observed negativity for SS in
this nucleus, among the foetal deaths, only in 8 of the
13 SIUD and in no stillbirths who died of known causes.
On the contrary, among the infant deaths, the HypoglN
was positive for the SS in 13 of the 24 SIDS cases and
only in 1 subject who died of a known cause.
Although the HypoglN is not included among the clas-
sically defined respiratory centres, its motor neurons,
which innervate intrinsic and extrinsic muscles of the
tongue, are known to produce peaks of activity that co-
incide with specific phases of respiration after birth [34,
38]. In fact, in the HypoglN different populations of
motoneurons have been identified to act during inspi-
ration, expiration and transitional phases [38]. In par-
ticular, the motoneurons that control the tonus of the
extrinsic tongue muscles are important in maintaining
a patent airway, especially during inspiration.
The different functional behaviour of the HypoglN
as regards SS could reflect a delayed maturation of this
nucleus in both prenatal and postnatal sudden deaths.
Therefore, it is possible that abnormalities in the dis-
tribution of SS in the HypoglN before and after birth may
contribute to the induction of both fatal breathing move-
ments in foetuses and abnormal ventilatory control in
infants leading to irreversible apneic phenomena.
CONCLUSIONS
In this study we postulate that:
1) The SS neurotransmitter in the human CNS is an
important foetal breathing-inhibitor, but it becomes
important to the physiological control of respiration
immediately after delivery.
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2) Functional alterations of the HypoglN, attributable
to wrong distribution of SS, can occur in both sud-
den perinatal and infant deaths, without any evi-
dence of structural alteration of the brainstem, in-
cluding ArcN hypoplasia, which is the histological
finding most frequently observed in such cases.
Thus, the present immunohistochemical study sug-
gests a plausible explanation in a group of SIUD,
SNUD and SIDS that remained unexplained after a
thorough case investigation, including a complete
autopsy with in-depth histological examination of
cardiorespiratory innervation, according to the pro-
tocol routinely followed in our Institute.
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